These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 23688065

  • 1. VEGF, M-CSF and CA 15-3 as a new tumor marker panel in breast malignancies: a multivariate analysis with ROC curve.
    Ławicki S, Będkowska GE, Szmitkowski M.
    Growth Factors; 2013 Jun; 31(3):98-105. PubMed ID: 23688065
    [Abstract] [Full Text] [Related]

  • 2. Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients.
    Ławicki S, Będkowska GE, Wojtukiewicz M, Szmitkowski M.
    Adv Med Sci; 2013 Jun; 58(2):207-15. PubMed ID: 23846151
    [Abstract] [Full Text] [Related]

  • 3. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
    Ławicki S, Szmitkowski M, Wojtukiewicz M.
    Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
    [Abstract] [Full Text] [Related]

  • 4. Hematopoietic cytokines as tumor markers in gynecological malignancies: a multivariate analysis with ROC curve in endometrial cancer patients.
    Lawicki S, Będkowska GE, Gacuta-Szumarska E, Szmitkowski M.
    Growth Factors; 2012 Feb; 30(1):29-36. PubMed ID: 22010785
    [Abstract] [Full Text] [Related]

  • 5. [The plasma levels and diagnostic utility of selected hematopoietic growth factors (HGFs) in breast cancer patients].
    Ławicki S, Czygier M, Wojtukiewicz M, Szmitkowski M.
    Przegl Lek; 2010 Feb; 67(12):1314-8. PubMed ID: 21591359
    [Abstract] [Full Text] [Related]

  • 6. Plasma Levels and Diagnostic Utility of M-CSF, MMP-2 and its Inhibitor TIMP-2 in the Diagnostics of Breast Cancer Patients.
    Ławicki S, Zajkowska M, Głażewska EK, Będkowska GE, Szmitkowski M.
    Clin Lab; 2016 Sep 01; 62(9):1661-1669. PubMed ID: 28164586
    [Abstract] [Full Text] [Related]

  • 7. Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer.
    Ławicki S, Głażewska EK, Sobolewska M, Będkowska GE, Szmitkowski M.
    Ann Lab Med; 2016 May 01; 36(3):223-9. PubMed ID: 26915610
    [Abstract] [Full Text] [Related]

  • 8. [The plasma levels and diagnostic utility of granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage - colony stimulating factor (GM-CSF) in patients with I and II stage of breast cancer].
    Ławicki S, Czygier M, Wojtukiewicz M, Szmitkowski M.
    Przegl Lek; 2009 May 01; 66(7):365-9. PubMed ID: 20043577
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic Power of Vascular Endothelial Growth Factor and Macrophage Colony-Stimulating Factor in Breast Cancer Patients Based on ROC Analysis.
    Zajkowska M, Głażewska EK, Będkowska GE, Chorąży P, Szmitkowski M, Ławicki S.
    Mediators Inflamm; 2016 May 01; 2016():5962946. PubMed ID: 27445439
    [Abstract] [Full Text] [Related]

  • 10. [The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients].
    Ławicki S, Czygier M, Omyła J, Bedkowska E, Szmitkowski M.
    Pol Merkur Lekarski; 2007 Oct 01; 23(136):259-63. PubMed ID: 18293847
    [Abstract] [Full Text] [Related]

  • 11. Plasma levels and diagnostic utility of VEGF, MMP-2 and TIMP-2 in the diagnostics of breast cancer patients.
    Ławicki S, Zajkowska M, Głażewska EK, Będkowska GE, Szmitkowski M.
    Biomarkers; 2017 Mar 01; 22(2):157-164. PubMed ID: 27775427
    [Abstract] [Full Text] [Related]

  • 12. Chemiluminometric determination of tissue polypeptide antigen (TPA), cancer antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison with vascular endothelial growth factor (VEGF) in follow-up of breast cancer.
    Findeisen R, Albrecht S, Richter B, Deutschmann K, Zimmermann T, Distler W.
    Luminescence; 2000 Mar 01; 15(5):283-9. PubMed ID: 11038485
    [Abstract] [Full Text] [Related]

  • 13. [The plasma levels and diagnostic utility of granulocyte colony stimulating factor (G-CSF) and macrophage - colony stimulating factor (M-CSF) in ovarian cancer patients].
    ławicki S, Czygier M, Gacuta-Szumarska E, Knapp P, Szmitkowski M.
    Pol Merkur Lekarski; 2006 Nov 01; 21(125):465-8. PubMed ID: 17345841
    [Abstract] [Full Text] [Related]

  • 14. Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers.
    Sidorkiewicz I, Zbucka-Krętowska M, Zaręba K, Lubowicka E, Zajkowska M, Szmitkowski M, Gacuta E, Ławicki S.
    BMC Cancer; 2019 Apr 29; 19(1):398. PubMed ID: 31035945
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic power of VEGF, MMP-9 and TIMP-1 in patients with breast cancer. A multivariate statistical analysis with ROC curve.
    Zajkowska M, Gacuta E, Kozłowska S, Lubowicka E, Głażewska EK, Chrostek L, Szmitkowski M, Pawłowski P, Zbucka-Krętowska M, Ławicki S.
    Adv Med Sci; 2019 Mar 29; 64(1):1-8. PubMed ID: 30227310
    [Abstract] [Full Text] [Related]

  • 16. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor.
    Kaminska J, Kowalska M, Kotowicz B, Fuksiewicz M, Glogowski M, Wojcik E, Chechlinska M, Steffen J.
    Oncology; 2006 Mar 29; 70(2):115-25. PubMed ID: 16645324
    [Abstract] [Full Text] [Related]

  • 17. [The plasma levels and diagnostic utility of stem cell factor (SCF) and macrophage-colony stimulating factor (M-CSF) in cervical cancer patients].
    Lawicki S, Bedkowska E, Gacuta-Szumarska E, Knapp P, Szmitkowski M.
    Pol Merkur Lekarski; 2008 Jul 29; 25(145):38-42. PubMed ID: 18839612
    [Abstract] [Full Text] [Related]

  • 18. [Plasma level of macrophage-colony stimulating factor (M-CSF) in the course of breast cancer treatment].
    Lawicki S, Omyła J, Mroczko B, Szmitkowski M, Czygier M.
    Pol Arch Med Wewn; 2004 Oct 29; 112(4):1181-7. PubMed ID: 15773430
    [Abstract] [Full Text] [Related]

  • 19. Comparative evaluation of plasma levels and diagnostic values of macrophage-colony stimulating factor in patients with breast cancer and benign tumors.
    Ławicki S, Czygier M, Bedkowska E, Wojtukiewicz M, Szmitkowski M.
    Pol Arch Med Wewn; 2008 Sep 29; 118(9):464-9. PubMed ID: 18846980
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.